drugset / Trial / NCT02232763
Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria
Phase 3
Completed
58 enrolled
Seoul National University Hospital
Ministry of Food and Drug Safety, Korea · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The investigators hypothesize that using Losartan would help decrease proteinuria in pediatric chronic kidney disease with tubular proteinuria.
Timeline
- Start
- 2014-09
- Primary completion
- 2016-07
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | — | — |